microdose retatrutide for Weight Loss: TRIUMPH-1 Results, Cost, Insurance Retatrutide: A Promising Solution for

Confused about where to start your metabolic health journey

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move

The prevalence of type 2 diabetes (T2D) is increasing worldwide, with many patients developing long-term complications that affect their cardiovascular, urin...

Novo Nordisk filed another petition with the FDA seeking to block compounding pharmacies from making versions of one of its GLP-1 drugs

Medical weight loss support with GLP-1 medications at Sweetgrass in Charleston, SC

The war is on between compounding pharmacies making knockoff versions of popular weight loss drugs and pharma giants Novo Nordisk and Eli Lilly, who want to protect their right to sell their patent | Novo Nordisk has asked the FDA to prevent compounders from manufacturing copycat versions of its juggernaut diabetes and obesity treatments Ozempic and Wegovy, claiming the drugs are too complex to safely replicate.